Related references
Note: Only part of the references are listed.Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS)
Mayank D. Bhavsar et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors
S. Kommareddy et al.
CANCER GENE THERAPY (2007)
Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery
Sushma Kommareddy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Oral gene delivery:: Design of polymeric carrier systems shielding toward intestinal enzymatic attack
Ronny Martien et al.
BIOPOLYMERS (2006)
Galanin in the trinitrobenzene sulfonic acid rat model of experimental colitis
Talero Elena et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Natural polymers for gene delivery and tissue engineering
Jiyoung M. Dang et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
IL-10 deficiency leads to somatic mutations in a model of IBD
Y Sato et al.
CARCINOGENESIS (2006)
New genes in inflammatory bowel disease: lessons for complex diseases?
DR Gaya et al.
LANCET (2006)
Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and D fibers
S Lecollinet et al.
JOURNAL OF VIROLOGY (2006)
Evolving knowledge and therapy of inflammatory bowel disease
JR Korzenik et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design
MD Bhavsar et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione
S Kommareddy et al.
BIOCONJUGATE CHEMISTRY (2005)
State of the art: IBD therapy and clinical trials in IBD
KL Isaacs et al.
INFLAMMATORY BOWEL DISEASES (2005)
Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides
S Fichtner-Feigl et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Systemic administration of the chemokine macrophage inflammatory protein 1α exacerbates inflammatory bowel disease in a mouse model
SLF Pender et al.
GUT (2005)
Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice:: correlation between symptoms and inflammation
S Melgar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles:: In vitro and in vivo studies
G Kaul et al.
PHARMACEUTICAL RESEARCH (2005)
Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles
G Kaul et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
IL-10 and its related cytokines for treatment of inflammatory bowel disease
Ming-Cai Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis
JO Lindsay et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy
S Mansouri et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
The promise of gene therapy in gastrointestinal and liver diseases
J Prieto et al.
GUT (2003)
IL-10 gene therapy prevents TNBS-induced colitis
J Lindsay et al.
GENE THERAPY (2002)
Inflammatory bowel disease: new insights into pathogenesis and treatment
S Ardizzone et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery
G Kaul et al.
PHARMACEUTICAL RESEARCH (2002)
New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease
H Nakase et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10
JO Lindsay et al.
JOURNAL OF IMMUNOLOGY (2001)
Prospects for research in inflammatory bowel disease
RS Blumberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat
MN Ajuebor et al.
JOURNAL OF IMMUNOLOGY (2001)
IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease
C Gasche et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Interleukin 10 gene transfer prevents experimental colitis in rats
G Barbara et al.
GUT (2000)
Synthetic DNA delivery systems
D Luo et al.
NATURE BIOTECHNOLOGY (2000)
Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency
B Egger et al.
DIGESTION (2000)
Share Paper
